Eide Per Kristian, Hole Kjell
Department of Physiology, University of Bergen, Årstadveien 19, N-5009 BergenNorway.
Pain. 1988 Mar;32(3):333-340. doi: 10.1016/0304-3959(88)90045-0.
The tail-flick and increasing temperature hot-plate tests were employed to study the effects of acute or chronic treatment with zimelidine, alaproclate or chlorimipramine on nociception and response to 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) in mice. A single dose of the serotonin (5-HT) uptake inhibitors produced antinociception in the hot-plate test but not in the tail-flick test. After chronic administration, reduced tail-flick latencies were demonstrated 24, 48, 72 and 144 h after withdrawal of zimelidine treatment, 48 h after withdrawal of alaproclate and 48 and 96 h after withdrawal of chlorimipramine treatment. The hot-plate response temperatures were slightly lowered after chronic zimelidine treatment but not after treatment with alaproclate or chlorimipramine. The response to 5-MeODMT was not altered by a single dose of the 5-HT uptake inhibitors, however, after withdrawal of chronic treatment this response was increased in the tail-flick test but not in the hot-plate test. It was concluded that acute and chronic treatment with 5-HT uptake inhibitors modulate nociception differently, and that chronic treatment induces supersensitivity of spinal postsynaptic 5-HT receptors. Different modulation of different 5-HT receptor subpopulations by these compounds may possibly contribute to the test-dependent results.
采用甩尾试验和热板温度递增试验,研究齐美利定、阿普氯胺或氯米帕明急性或慢性给药对小鼠痛觉及对5-甲氧基-N,N-二甲基色胺(5-MeODMT)反应的影响。单剂量的5-羟色胺(5-HT)摄取抑制剂在热板试验中产生抗伤害感受作用,但在甩尾试验中未产生此作用。慢性给药后,停用齐美利定治疗24、48、72和144小时后、停用阿普氯胺48小时后以及停用氯米帕明治疗48和96小时后,甩尾潜伏期缩短。慢性齐美利定治疗后热板反应温度略有降低,但阿普氯胺或氯米帕明治疗后未出现此情况。单剂量的5-HT摄取抑制剂未改变对5-MeODMT的反应,然而,慢性治疗停药后,甩尾试验中此反应增强,但热板试验中未增强。得出的结论是,5-HT摄取抑制剂的急性和慢性治疗对痛觉的调节方式不同,且慢性治疗可诱导脊髓突触后5-HT受体超敏。这些化合物对不同5-HT受体亚群的不同调节可能导致了试验依赖性结果。